MicroBase Technology Corp (3184) Fair Value & Analysis
Technology · TW · Market cap 1.2B TWD
Fair value as of: Jun 24, 2026
Analysis
MicroBase Technology Corp (3184) currently trades at 17.45 TWD, while our model-based Fair Value estimate is 11.19 TWD — implying the stock looks roughly 35.9% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, lower respiratory tract infections, and chronic respiratory diseases; Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles. MicroBase Technology Corp. was founded in 1997 and is based in Taoyuan City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is MicroBase Technology Corp (3184) undervalued?
What is the fair value of 3184?
What is the quality score of 3184?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.